CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 452 enrolled
Drug / intervention
UMS Strategy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02248857
NCT02248857N/ACompleted
CompareCT.gov

Promoting the Universal Medication Schedule Via Mobile and EHR Technologies: A Physician-randomized Control Trial

Northwestern University·interventional·Posted Sep 25, 2014·Updated Mar 25, 2019

In Brief

A clinical study evaluating UMS Strategy and SMS Texting Reminders for Type 2 Diabetes. Completed, enrolled 452 participants across 1 site.

Detailed Summary

The purpose of this study test the effectiveness of the Universal Medication Schedule (UMS), which was designed as a strategy to standardize and simplify medication instructions to support safe and effective prescription drug use among diabetic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 25, 2014
Enrollment StartDec 1, 2014
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 11.8 years ago

Interventions

UMS Strategyother

Patients of providers randomized to the UMS arm will receive study-related educational tools at their primary care visit to support the understanding, regimen consolidation, and use of prescriptions.

SMS Texting Remindersother

In addition to the components from the UMS strategy arm, patients will receive daily text reminders for 7 days, with the option of extending reminders, following a study medication prescription.